{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:06:27Z","timestamp":1794877587059,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Radiotherapy induces and promotes innate and adaptive immunity in which host STING plays an important role. However, radioresistance in irradiated tumors can also develop, resulting in relapse. Here we report a mechanism by which extrinsic resistance develops after local ablative radiation that relies on the immunosuppressive action of STING. The STING\/type I interferon pathway enhances suppressive inflammation in tumors by recruiting myeloid cells in part via the CCR2 pathway. Germ-line knockouts of CCR2 or treatment with an anti-CCR2 antibody results in blockade of radiation-induced MDSC infiltration. Treatment with anti-CCR2 antibody alleviates immunosuppression following activation of the STING pathway, enhancing the anti-tumor effects of STING agonists and radiotherapy. We propose that radiation-induced STING activation is immunosuppressive due to (monocytic) M-MDSC infiltration, which results in tumor radioresistance. Furthermore, the immunosuppressive effects of radiotherapy and STING agonists can be abrogated in humans by a translational strategy involving anti-CCR2 antibody treatment to improve radiotherapy.<\/jats:p>","DOI":"10.1038\/s41467-017-01566-5","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T15:10:22Z","timestamp":1510931422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":476,"title":["Host STING-dependent MDSC mobilization drives extrinsic radiation resistance"],"prefix":"10.1038","volume":"8","author":[{"given":"Hua","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liufu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Mauceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-825X","authenticated-orcid":false,"given":"Yang-Xin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph R.","family":"Weichselbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"1566_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00411-013-0497-2","volume":"53","author":"M Orth","year":"2014","unstructured":"Orth, M. et al. Current concepts in clinical radiation oncology. Radiat. Environ. Biophys. \n                           53, 1\u201329 (2014).","journal-title":"Radiat. Environ. Biophys."},{"key":"1566_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","volume":"114","author":"Y Lee","year":"2009","unstructured":"Lee, Y. et al. Therapeutic effects of ablative radiation on local tumor require CD8\u2009+\u2009T cells: changing strategies for cancer treatment. Blood \n                           114, 589\u2013595 (2009).","journal-title":"Blood"},{"key":"1566_CR3","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.4049\/jimmunol.1202612","volume":"190","author":"H Liang","year":"2013","unstructured":"Liang, H. et al. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. J. Immunol. \n                           190, 5874\u20135881 (2013).","journal-title":"J. Immunol."},{"key":"1566_CR4","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","volume":"71","author":"BC Burnette","year":"2011","unstructured":"Burnette, B. C. et al. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. \n                           71, 2488\u20132496 (2011).","journal-title":"Cancer Res."},{"key":"1566_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity \n                           41, 843\u2013852 (2014).","journal-title":"Immunity"},{"key":"1566_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1078-0432.CCR-14-3110","volume":"22","author":"L Deng","year":"2016","unstructured":"Deng, L., Liang, H., Fu, S., Weichselbaum, R. R. & Fu, Y. X. From DNA damage to nucleic acid sensing: a strategy to enhance radiation therapy. Clin. Cancer Res. \n                           22, 20\u201325 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1566_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo, S. R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity \n                           41, 830\u2013842 (2014).","journal-title":"Immunity"},{"key":"1566_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/PPO.0b013e318292e4e3","volume":"19","author":"H Willers","year":"2013","unstructured":"Willers, H., Azzoli, C. G., Santivasi, W. L. & Xia, F. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J. \n                           19, 200\u2013207 (2013).","journal-title":"Cancer J."},{"key":"1566_CR9","doi-asserted-by":"crossref","unstructured":"Weichselbaum, R. R., Liang, H., Deng, L. & Fu, Y. X. Radiotherapy and immunotherapy: a beneficial liaison? Nat. Rev. Clin. Oncol. 14, 365-379 (2017).","DOI":"10.1038\/nrclinonc.2016.211"},{"key":"1566_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4306","volume":"7","author":"J Fu","year":"2015","unstructured":"Fu, J. et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci. Transl. Med. \n                           7, 283ra52 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1566_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science \n                           340, 202\u2013207 (2013).","journal-title":"Science"},{"key":"1566_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science \n                           340, 207\u2013211 (2013).","journal-title":"Science"},{"key":"1566_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semradonc.2014.07.007","volume":"25","author":"D Schaue","year":"2015","unstructured":"Schaue, D. et al. Radiation and inflammation. Semin. Radiat. Oncol. \n                           25, 4\u201310 (2015).","journal-title":"Semin. Radiat. Oncol."},{"key":"1566_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semradonc.2014.07.008","volume":"25","author":"RE Vatner","year":"2015","unstructured":"Vatner, R. E. & Formenti, S. C. Myeloid-derived cells in tumors: effects of radiation. Semin. Radiat. Oncol. \n                           25, 18\u201327 (2015).","journal-title":"Semin. Radiat. Oncol."},{"key":"1566_CR15","volume":"2","author":"D Schaue","year":"2012","unstructured":"Schaue, D., Xie, M. W., Ratikan, J. A. & McBride, W. H. Regulatory T cells in radiotherapeutic responses. Front. Oncol. \n                           2, 90 (2012).","journal-title":"Front. Oncol."},{"key":"1566_CR16","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","volume":"111","author":"K Movahedi","year":"2008","unstructured":"Movahedi, K. et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood \n                           111, 4233\u20134244 (2008).","journal-title":"Blood"},{"key":"1566_CR17","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn, J. I., Nagaraj, S., Collazo, M. & Gabrilovich, D. I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. \n                           181, 5791\u20135802 (2008).","journal-title":"J. Immunol."},{"key":"1566_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1182\/blood-2012-01-403386","volume":"120","author":"S Willenborg","year":"2012","unstructured":"Willenborg, S. et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood \n                           120, 613\u2013625 (2012).","journal-title":"Blood"},{"key":"1566_CR19","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1172\/JCI40310","volume":"120","author":"Y Si","year":"2010","unstructured":"Si, Y., Tsou, C. L., Croft, K. & Charo, I. F. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J. Clin. Invest. \n                           120, 1192\u20131203 (2010).","journal-title":"J. Clin. Invest."},{"key":"1566_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2012.05.023","volume":"22","author":"MJ Wolf","year":"2012","unstructured":"Wolf, M. J. et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell \n                           22, 91\u2013105 (2012).","journal-title":"Cancer Cell"},{"key":"1566_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell \n                           141, 39\u201351 (2010).","journal-title":"Cell"},{"key":"1566_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature \n                           475, 222\u2013225 (2011).","journal-title":"Nature"},{"key":"1566_CR23","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","volume":"166","author":"M Mack","year":"2001","unstructured":"Mack, M. et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. \n                           166, 4697\u20134704 (2001).","journal-title":"J. Immunol."},{"key":"1566_CR24","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1093\/brain\/awp144","volume":"132","author":"A Mildner","year":"2009","unstructured":"Mildner, A. et al. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain \n                           132, 2487\u20132500 (2009).","journal-title":"Brain"},{"key":"1566_CR25","doi-asserted-by":"publisher","DOI":"10.4161\/onci.25668","volume":"2","author":"H Liang","year":"2013","unstructured":"Liang, H., Deng, L., Burnette, B., Weichselbaum, R. R. & Fu, Y. X. Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells. Oncoimmunology \n                           2, e25668 (2013).","journal-title":"Oncoimmunology"},{"key":"1566_CR26","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi, C. & Pamer, E. G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. \n                           11, 762\u2013774 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"1566_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O De Henau","year":"2016","unstructured":"De Henau, O. et al. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells. Nature \n                           539, 443\u2013447 (2016).","journal-title":"Nature"},{"key":"1566_CR28","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.4049\/jimmunol.0901316","volume":"183","author":"WA Szymczak","year":"2009","unstructured":"Szymczak, W. A. & Deepe, G. S. Jr. The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J. Immunol. \n                           183, 1964\u20131974 (2009).","journal-title":"J. Immunol."},{"key":"1566_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1165\/rcmb.2005-0239OC","volume":"35","author":"BB Moore","year":"2006","unstructured":"Moore, B. B. et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. \n                           35, 175\u2013181 (2006).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1566_CR30","doi-asserted-by":"crossref","unstructured":"Kalbasi, A. et al. Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma. Clin. Cancer. Res. 23, 137-148 (2016).","DOI":"10.1158\/1078-0432.CCR-16-0870"},{"key":"1566_CR31","doi-asserted-by":"crossref","unstructured":"Nywening, T. M. et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 17, 651-662 (2016).","DOI":"10.1016\/S1470-2045(16)00078-4"},{"key":"1566_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","volume":"34","author":"MB Fuertes","year":"2013","unstructured":"Fuertes, M. B., Woo, S. R., Burnett, B., Fu, Y. X. & Gajewski, T. F. Type I interferon response and innate immune sensing of cancer. Trends Immunol. \n                           34, 67\u201373 (2013).","journal-title":"Trends Immunol."},{"key":"1566_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-med-052814-023338","volume":"67","author":"FJ Barrat","year":"2016","unstructured":"Barrat, F. J., Elkon, K. B. & Fitzgerald, K. A. Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity. Annu. Rev. Med. \n                           67, 323\u2013336 (2016).","journal-title":"Annu. Rev. Med."},{"key":"1566_CR34","doi-asserted-by":"publisher","first-page":"26496","DOI":"10.18632\/oncotarget.8420","volume":"7","author":"DR Ranoa","year":"2016","unstructured":"Ranoa, D. R. et al. Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs. Oncotarget \n                           7, 26496\u201326515 (2016).","journal-title":"Oncotarget"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01566-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:16:30Z","timestamp":1671732990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01566-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1566"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01566-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1736"}}